Literature DB >> 30209805

Mesh versus non-mesh for inguinal and femoral hernia repair.

Kathleen Lockhart1, Douglas Dunn, Shawn Teo, Jessica Y Ng, Manvinder Dhillon, Edward Teo, Mieke L van Driel.   

Abstract

BACKGROUND: This is an update of a Cochrane Review first published in 2001.Hernias are protrusions of all or part of an organ through the body wall that normally contains it. Groin hernias include inguinal (96%) and femoral (4%) hernias, and are often symptomatic with discomfort. They are extremely common, with an estimated lifetime risk in men of 27%. Occasionally they may present as emergencies with complications such as bowel incarceration, obstruction and strangulation. The definitive treatment of all hernias is surgical repair, inguinal hernia repair being one of the most common surgical procedures performed. Mesh (hernioplasty) and the traditional non-mesh repairs (herniorrhaphy) are commonly used, with an increasing preference towards mesh repairs in high-income countries.
OBJECTIVES: To evaluate the benefits and harms of different inguinal and femoral hernia repair techniques in adults, specifically comparing closure with mesh versus without mesh. Outcomes include hernia recurrence, complications (including neurovascular or visceral injury, haematoma, seroma, testicular injury, infection, postoperative pain), mortality, duration of operation, postoperative hospital stay and time to return to activities of daily living. SEARCH
METHODS: We searched the following databases on 9 May 2018: Cochrane Colorectal Cancer Group Specialized Register, Cochrane Central Register of Controlled Trials (Issue 1), Ovid MEDLINE (from 1950), Ovid Embase (from 1974) and Web of Science (from 1900). Furthermore, we checked the WHO International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov for trials. We applied no language or publication restrictions. We also searched the reference lists of included trials and review articles. SELECTION CRITERIA: We included randomised controlled trials of mesh compared to non-mesh inguinal or femoral hernia repairs in adults over the age of 18 years. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. Where available, we collected information on adverse effects. We presented dichotomous data as risk ratios, and where possible we calculated the number needed to treat for an additional beneficial outcome (NNTB). We presented continuous data as mean difference. Analysis of missing data was based on intention-to-treat principles, and we assessed heterogeneity using an evaluation of clinical and methodological diversity, Chi2 test and I2 statistic. We used GRADE to assess the quality of evidence for each outcome. MAIN
RESULTS: We included 25 studies (6293 participants) in this review. All included studies specified inguinal hernias, and two studies reported that femoral hernias were included.Mesh repair probably reduces the risk of hernia recurrence compared to non-mesh repair (21 studies, 5575 participants; RR 0.46, 95% CI 0.26 to 0.80, I2 = 44%, moderate-quality evidence). In absolute numbers, one hernia recurrence was prevented for every 46 mesh repairs compared with non-mesh repairs. Twenty-four studies (6293 participants) assessed a wide range of complications with varying follow-up times. Neurovascular and visceral injuries were more common in non-mesh repair groups (RR 0.61, 95% CI 0.49 to 0.76, I2 = 0%, NNTB = 22, high-quality evidence). Wound infection was found slightly more commonly in the mesh group (20 studies, 4540 participants; RR 1.29, 95% CI 0.89 to 1.86, I2 = 0%, NNTB = 200, low-quality evidence). Mesh repair reduced the risk of haematoma compared to non-mesh repair (15 studies, 3773 participants; RR 0.88, 95% CI 0.68 to 1.13, I2 = 0%, NNTB = 143, low-quality evidence). Seromas probably occur more frequently with mesh repair than with non-mesh repair (14 studies, 2640 participants; RR 1.63, 95% CI 1.03 to 2.59, I2 = 0%, NNTB = 72, moderate-quality evidence), as does wound swelling (two studies, 388 participants; RR 4.56, 95% CI 1.02 to 20.48, I2 = 33%, NNTB = 72, moderate-quality evidence). The comparative effect on wound dehiscence is uncertain due to wide confidence intervals (two studies, 329 participants; RR 0.55, 95% CI 0.12 to 2.48, I2 = 37% NNTB = 77, low-quality evidence). Testicular complications showed nearly equivocal results; they probably occurred slightly more often in the mesh group however the confidence interval around the effect was wide (14 studies, 3741 participants; RR 1.06, 95% CI 0.63 to 1.76, I2 = 0%, NNTB = 2000, low-quality evidence). Mesh reduced the risk of postoperative urinary retention compared to non-mesh (eight studies, 1539 participants; RR 0.53, 95% CI 0.38 to 0.73, I2 = 56%, NNTB = 16, moderate-quality evidence).Postoperative and chronic pain could not be compared due to variations in measurement methods and follow-up time (low-quality evidence).No deaths occurred during the follow-up periods reported in the seven studies (2546 participants) reporting this outcome (high-quality evidence).The average operating time was longer for non-mesh repairs by a mean of 4 minutes 22 seconds, despite wide variation across the studies regarding size and direction of effect, thus this result is uncertain (20 studies, 4148 participants; 95% CI -6.85 to -1.60, I2= 97%, very low-quality evidence). Hospital stay may be shorter with mesh repair, by 0.6 days (12 studies, 2966 participants; 95% CI -0.86 to -0.34, I2 = 98%, low-quality evidence), and participants undergoing mesh repairs may return to normal activities of daily living a mean of 2.87 days sooner than those with non-mesh repair (10 studies, 3183 participants; 95% CI -4.42 to -1.32, I2 = 96%, low-quality evidence), although the results of both these outcomes are also limited by wide variation in the size and direction of effect across the studies. AUTHORS'
CONCLUSIONS: Mesh and non-mesh repairs are effective surgical approaches in treating hernias, each demonstrating benefits in different areas. Compared to non-mesh repairs, mesh repairs probably reduce the rate of hernia recurrence, and reduce visceral or neurovascular injuries, making mesh repair a common repair approach. Mesh repairs may result in a reduced length of hospital stay and time to return to activities of daily living, but these results are uncertain due to variation in the results of the studies. Non-mesh repair is less likely to cause seroma formation and has been favoured in low-income countries due to low cost and reduced availability of mesh materials. Risk of bias in the included studies was low to moderate and generally handled well by study authors, with attention to details of allocation, blinding, attrition and reporting.

Entities:  

Mesh:

Year:  2018        PMID: 30209805      PMCID: PMC6513260          DOI: 10.1002/14651858.CD011517.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  73 in total

Review 1.  Clinical practice. Groin hernias in adults.

Authors:  Robert J Fitzgibbons; R Armour Forse
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

2.  Smoking is a risk factor for recurrence of groin hernia.

Authors:  Lars Tue Sorensen; Esbern Friis; Torben Jorgensen; Bo Vennits; Betina Ristorp Andersen; Gitte Iben Rasmussen; Johan Kjaergaard
Journal:  World J Surg       Date:  2002-01-02       Impact factor: 3.352

Review 3.  Low-cost mesh for inguinal hernia repair in resource-limited settings.

Authors:  J Yang; D Papandria; D Rhee; H Perry; F Abdullah
Journal:  Hernia       Date:  2011-05-24       Impact factor: 4.739

4.  Danish Hernia Database recommendations for the management of inguinal and femoral hernia in adults.

Authors:  Jacob Rosenberg; Thue Bisgaard; Henrik Kehlet; Pål Wara; Torsten Asmussen; Poul Juul; Lasse Strand; Finn Heidmann Andersen; Morten Bay-Nielsen
Journal:  Dan Med Bull       Date:  2011-02

5.  Lichtenstein or darn procedure in inguinal hernia repair: a prospective randomized comparative study.

Authors:  H F Kucuk; H E Sikar; N Kurt; H Uzun; M Eser; F Tutal; Y Tuncer
Journal:  Hernia       Date:  2010-05-12       Impact factor: 4.739

6.  Randomized clinical trial comparing 5-year recurrence rate after laparoscopic versus Shouldice repair of primary inguinal hernia.

Authors:  D Arvidsson; F H Berndsen; L G Larsson; C-E Leijonmarck; G Rimbäck; C Rudberg; S Smedberg; L Spangen; A Montgomery
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

7.  Prospective, randomized-controlled trial comparing postoperative pain after plug and patch open repair with totally extraperitoneal inguinal hernia repair.

Authors:  F Aigner; F Augustin; C Kaufmann; A Schlager; H Ulmer; J Pratschke; T Schmid
Journal:  Hernia       Date:  2013-06-18       Impact factor: 4.739

8.  Endoscopic extraperitoneal herniorrhaphy. A 5-year experience.

Authors:  G Ferzli; P Sayad; F Huie; A Hallak; H Usal
Journal:  Surg Endosc       Date:  1998-11       Impact factor: 4.584

9.  Low recurrence rate after laparoscopic (TEP) and open (Lichtenstein) inguinal hernia repair: a randomized, multicenter trial with 5-year follow-up.

Authors:  Arne S Eklund; Agneta K Montgomery; Ib C Rasmussen; Rune P Sandbue; Leif A Bergkvist; Claes R Rudberg
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

Review 10.  Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for inguinal hernia repair.

Authors:  B L Wake; K McCormack; C Fraser; L Vale; J Perez; A M Grant
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25
View more
  31 in total

1.  Predictive factors for the development of surgical site infection in adults undergoing initial open inguinal hernia repair.

Authors:  J Sereysky; A Parsikia; M E Stone; M Castaldi; J McNelis
Journal:  Hernia       Date:  2019-09-24       Impact factor: 4.739

2.  Quality and reliability evaluation of current Internet information regarding mesh use in inguinal hernia surgery using HONcode and the DISCERN instrument.

Authors:  Anna C Fullard; Sean M Johnston; Dermot J Hehir
Journal:  Hernia       Date:  2021-04-14       Impact factor: 4.739

3.  The value and role of mosquito meshes in low resource and poor income settings: author's reply.

Authors:  R Wiessner; M Philipp; R Lorenz
Journal:  Hernia       Date:  2021-01-11       Impact factor: 4.739

4.  Shouldice standard 2020: review of the current literature and results of an international consensus meeting.

Authors:  R Lorenz; G Arlt; J Conze; R Fortelny; J Gorjanc; A Koch; J Morrison; V Oprea; G Campanelli
Journal:  Hernia       Date:  2021-01-27       Impact factor: 4.739

5.  Bowel obstruction as a serious complication of patients with femoral hernia.

Authors:  Mauricio Gonzalez-Urquijo; Valeria C Tellez-Giron; Emmanuel Martinez-Ledesma; Mario Rodarte-Shade; Oscar J Estrada-Cortinas; Gerardo Gil-Galindo
Journal:  Surg Today       Date:  2020-10-08       Impact factor: 2.549

6.  Minimising recurrence after primary femoral hernia repair; is mesh mandatory?

Authors:  D R Clyde; A de Beaux; B Tulloh; J R O'Neill
Journal:  Hernia       Date:  2019-08-12       Impact factor: 4.739

7.  Could polypropylene mesh impair male reproductive organs? Experimental study with different methods of implantation.

Authors:  S H B Damous; L L Damous; J S Miranda; E F S Montero; C Birolini; E M Utiyama
Journal:  Hernia       Date:  2020-04-18       Impact factor: 4.739

8.  Outcomes After Inguinal Hernia Repair With Mesh Performed by Medical Doctors and Surgeons in Ghana.

Authors:  Jessica H Beard; Michael Ohene-Yeboah; Stephen Tabiri; Joachim K A Amoako; Francis A Abantanga; Carrie A Sims; Pär Nordin; Andreas Wladis; Hobart W Harris; Jenny Löfgren
Journal:  JAMA Surg       Date:  2019-09-01       Impact factor: 14.766

9.  Improving surgical education in East Africa with a standardized hernia training program.

Authors:  R Lorenz; C Oppong; A Frunder; M Lechner; D M Sedgwick; A Tasi; R Wiessner
Journal:  Hernia       Date:  2020-03-10       Impact factor: 4.739

10.  Inguinal hernia mesh is safe in 1720 patients.

Authors:  Beau Forester; Mikhail Attaar; Maya Lach; Sebastian Chirayil; Kristine Kuchta; Woody Denham; John G Linn; Stephen P Haggerty; JoAnn Carbray; Michael Ujiki
Journal:  Surg Endosc       Date:  2021-03-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.